User:Dindocanillas.jr/sandbox

First Case in the Philipines
Background: The novel coronavirus (COVID-19) is responsible for more fatalities than the SARS coronavirus, despite being in the initial stage of a global pandemic. The first suspected case in the Philippines was investigated on January 22, 2020, and 633 suspected cases were reported as of March 1. We describe the clinical and epidemiological aspects of the first two confirmed COVID-19 cases in the Philippines, both admitted to the national infectious disease referral hospital in Manila.

Case presentation: Both patients were previously healthy Chinese nationals on vacation in the Philippines travelling as a couple during January 2020. Patient 1, a 39-year-old female, had symptoms of cough and sore throat and was admitted to San Lazaro Hospital in Manila on January 25. Physical examination was unremarkable. Influenza B, human coronavirus 229E, Staphylococcus aureus and Klebsiella pneumoniae were detected by PCR on initial nasopharyngeal/oropharyngeal (NPS/OPS) swabs. On January 30, SARS-CoV-2 viral RNA was reported to be detected by PCR on the initial swabs and she was identified as the first confirmed COVID-19 case in the Philippines. Her symptoms resolved, and she was discharged. Patient 2, a 44-year-old male, had symptoms of fever, cough, and chills. Influenza B and Streptococcus pneumoniae were detected by PCR on initial NPS/OPS swabs. He was treated for community-acquired pneumonia with intravenous antibiotics, but his condition deteriorated and he required intubation. On January 31, SARS-CoV-2 viral RNA was reported to be detected by PCR on the initial swabs, and he was identified as the 2nd confirmed COVID-19 infection in the Philippines. On February 1, the patient's condition deteriorated, and following a cardiac arrest, it was not possible to revive him. He was thus confirmed as the first COVID-19 death outside of China.

Number of cases
In Philippines, from 3 January 2020 to 8:48pm CEST, 6 October 2021, there have been 2,613,070 confirmed cases of COVID-19 with 38,828 deaths, reported to WHO. As of 22 September 2021, a total of 43,088,582 vaccine doses have been administered. COVID-19 affects different people in different ways. Most infected people will develop mild to moderate illness and recover without hospitalization.

Vaccines
How do vaccines differ? Vaccines differ in their composition and how they trigger the immune response to create antibodies. These antibodies protect the body from microorganisms and serve as protection once a person gets infected with disease. Vaccines can be inactivated, weakened or killed copies of the whole or part of the virus or bacteria, or genetic product (like mRNA vaccines) that creates protein copies without causing disease.

What are the possible side effects of vaccination? The possible side effects of a vaccine include pain, redness, itchiness or swelling at the injection site (which may last a few hours); fever; feeling of weakness or fatigue; headache; dizziness; diarrhea; or nausea. Consult the nearest healthcare professional if you experience any of these.

Vaccines Available
 * Pfizer/BioNTech
 * Moderna
 * Gamaleya
 * Sputnik Light
 * Sputnik V
 * Janssen (Johnson & Johnson)
 * Oxford/AstraZeneca
 * Bharat Biotech
 * Sinopharm (Beijing)
 * Sinopharm (Wuhan)
 * Sinovac
 * CoronaVac